| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 0.0002 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.2 | 0.0004 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |